Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T, Ejiri K, Kohno K, Nakahama M, Doi M, Munemasa M, Murakami M, Takaishi A, Kawai Y, Sato T, Sato K, Oka T, Takahashi N, Sakuragi S, Mima A, Enko K, Hosogi S, Nanba S, Hirami R, Nakamura K, Ito H; RINC Study Collaborators. Miyoshi T, et al. Among authors: takaishi a. Int J Cardiol. 2017 Jun 1;236:36-42. doi: 10.1016/j.ijcard.2017.02.028. Epub 2017 Feb 10. Int J Cardiol. 2017. PMID: 28214082 Clinical Trial.
Association between home-based exercise using a pedometer and clinical prognosis after endovascular treatment in patients with peripheral artery disease.
Kawamura K, Ejiri K, Toda H, Yamanaka T, Taniguchi M, Kawamoto K, Tokioka K, Naito Y, Yoshioka R, Karashima E, Fujio H, Fuke S, Fujiwara Y, Takaishi A, Seiyama K, Miyoshi T, Nakamura K, Ito H; ASHIMORI-IC Study. Kawamura K, et al. Among authors: takaishi a. J Cardiol. 2023 Feb;81(2):222-228. doi: 10.1016/j.jjcc.2022.09.005. Epub 2022 Sep 17. J Cardiol. 2023. PMID: 36126908 Free article.
Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trial.
Ejiri K, Miyoshi T, Kohno K, Nakahama M, Doi M, Munemasa M, Murakami M, Takaishi A, Nakamura K, Ito H. Ejiri K, et al. Among authors: takaishi a. Int J Cardiol Heart Vasc. 2018 Dec 26;22:55-60. doi: 10.1016/j.ijcha.2018.12.005. eCollection 2019 Mar. Int J Cardiol Heart Vasc. 2018. PMID: 30603663 Free PMC article.
Innovative clinical pathway shortened the length of hospital stay and prevented readmission in patients with acute decompensated heart failure.
Amioka N, Takaishi A, Nakamura K, Endo T, Iida T, Yamaji T, Mori H, Kishinoue T, Yasuhara K, Matsuo N, Tanimoto M, Nakano Y, Onishi N, Ueeda M, Ito H. Amioka N, et al. Among authors: takaishi a. J Cardiol. 2022 Sep;80(3):232-239. doi: 10.1016/j.jjcc.2022.03.014. Epub 2022 Apr 12. J Cardiol. 2022. PMID: 35428556 Free article.
Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial.
Naito R, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H; AFIRE Investigators. Naito R, et al. JAMA Cardiol. 2022 Aug 1;7(8):787-794. doi: 10.1001/jamacardio.2022.1561. JAMA Cardiol. 2022. PMID: 35704345 Free PMC article. Clinical Trial.
35 results